- Imagion Biosystems (IBX) has appointed Geoff Hollis as its new Chief Financial Officer (CFO)
- Geoff is replacing Brian Conn and will begin his new role on December 1
- Previously, Geoff has been a CFO for multiple ASX listed companies, such as Lifestyle Communities (LIC)
- This appointment supports the next phase of growth for the company as it aims to develop and commercialise its medical device technology
- Geoff replaces Brian Conn, who has been part of the Imagion team as a part-time CFO since 2017
- On the market today, Imagion is up 2.6 per cent and is trading for 7.9 cents per share
